Clarivate Plc (CLVT) concluded trading on Wednesday at a closing price of $5.09, with 4.4 million shares of worth about $22.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.29% during that period and on January 08, 2025 the price saw a loss of about -1.74%. Currently the company’s common shares owned by public are about 710.30M shares, out of which, 413.66M shares are available for trading.
Stock saw a price change of 0.20% in past 5 days and over the past one month there was a price change of -11.01%. Year-to-date (YTD), CLVT shares are showing a performance of 0.20% which decreased to -44.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.25 but also hit the highest price of $9.60 during that period. The average intraday trading volume for Clarivate Plc shares is 5.27 million. The stock is currently trading -1.16% below its 20-day simple moving average (SMA20), while that difference is down -4.97% for SMA50 and it goes to -17.48% lower than SMA200.
Clarivate Plc (NYSE: CLVT) currently have 710.30M outstanding shares and institutions hold larger chunk of about 65.53% of that.
The stock has a current market capitalization of $3.62B and its 3Y-monthly beta is at 1.16. It has posted earnings per share of -$1.99 in the same period. It has Quick Ratio of 0.88 while making debt-to-equity ratio of 0.86. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLVT, volatility over the week remained 3.18% while standing at 3.98% over the month.
Stock’s fiscal year EPS is expected to drop by -10.66% while it is estimated to increase by 1.72% in next year. EPS is likely to shrink at an annualized rate of 32.00% for next 5-years, compared to annual growth of 60.20% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Clarivate Plc (CLVT) stock as an Underweight in their note to investors on December 15, 2023, suggesting a price target of $8 for the stock. On October 16, 2023, Jefferies Upgrade their recommendations, while on September 08, 2023, Barclays Downgrade their ratings for the stock with a price target of $7. Stock get a Sector perform rating from RBC Capital Mkts on August 25, 2023.
